March 2019 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for March 2019. This roundup includes...
Undiagnosed Gestational Diabetes Ups Risk for Stillbirth
Women at risk for GDM who are screened, those diagnosed with GDM not at increased risk
Liquid Meal Replacements Cut Cardiometabolic Risk Factors
Effects observed in overweight/obese patients with T2DM; certainty of evidence low to moderate
Doctors Unclear on Legal Obligations in Caring for Patients With Disability
Doctors report having little formal training, have incorrect understanding of care for patients with disability
Shorter Reproductive Span May Up Risk for Dementia in Women
Dementia risk increased for menarche age ≥16 versus 13.0 years, natural menopause at <47.4 years
Long-Term Phentermine Use Safe, Effective for Weight Loss
No difference in cardiovascular disease, death seen between those taking the drug for >12 versus ≤3 months
Doctors With Malpractice Claims More Likely to Leave Medicine
Physicians with five or more malpractice claims more than twice as likely to go into solo practice
Frailty May Up Fracture Risk in Patients With Type 2 Diabetes
Diabetes patients have higher frailty scores, which are tied to risk for incident fragility fractures
FDA Grants Approval for Hypogonadism Treatment
Jatenzo indicated for men with low testosterone due to certain conditions
Endocrine Society, March 23-26
The Endocrine Society 101st Annual Meeting and Expo The annual meeting of the Endocrine Society (ENDO 2019) was held from March 23 to...
